E-LIB Suche - Ergebnisse für: Lew, Deborah S.

1

Mutations in Pre-mRNA Processing Factors 3, 8, and 31 Cause..:

Farkas, Michael H. ; Lew, Deborah S. ; Sousa, Maria E....
The American Journal of Pathology. 184 (2014) 10 - p. 2641-2652 , 2014

Link: https://doi.org/10.1016/..

2

Galectin-3 Promotes Müller Glia Clearance Phagocytosis via ..:

Lew, Deborah S ; McGrath, Morgan J ; Finnemann, Silvia C
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194531/. , 2022

Link: http://www.ncbi.nlm.nih...

3

Microglia Inhibition Delays Retinal Degeneration Due to Mer..:

Lew, Deborah S ; Mazzoni, Francesca ; Finnemann, Silvia C
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381113/. , 2020

Link: http://www.ncbi.nlm.nih...

4

Mutations in Pre-mRNA Processing Factors 3, 8, and 31 Cause..:

Farkas, Michael, H ; Lew, Deborah, S ; Sousa, Maria, E...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ajpath.2014.06.026. , 2014

Link: https://hal.science/hal-..

5

Mutations in Pre-mRNA Processing Factors 3, 8, and 31 Cause..:

Farkas, Michael, H ; Lew, Deborah, S ; Sousa, Maria, E...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ajpath.2014.06.026. , 2014

Link: https://hal.science/hal-..

6

Galectin-3 Promotes Müller Glia Clearance Phagocytosis via ..:

Deborah S. Lew ; Morgan J. McGrath ; Silvia C. Finnemann
https://www.frontiersin.org/articles/10.3389/fncel.2022.878260/full. , 2022

Link: https://doi.org/10.3389/..

7

Microglia Inhibition Delays Retinal Degeneration Due to Mer..:

Deborah S. Lew ; Francesca Mazzoni ; Silvia C. Finnemann
https://www.frontiersin.org/article/10.3389/fimmu.2020.01463/full. , 2020

Link: https://doi.org/10.3389/..

8

Safety of oral tazarotene in nodulocystic acne:

Lowe, Nicholas J. ; Lew-Kaya, Deborah ; Walker, Patricia S.
Journal of the American Academy of Dermatology. 50 (2004) 3 - p. P17 , 2004

Link: https://doi.org/10.1016/..

9

Oral tazarotene reduces comedones:

Tan, Jerry K.L. ; Lew-Kaya, Deborah ; Walker, Patricia S.
Journal of the American Academy of Dermatology. 50 (2004) 3 - p. P20 , 2004

Link: https://doi.org/10.1016/..

10

Photographic documentation of the efficacy of oral tazarote..:

Leyden, James J. ; Lew-Kaya, Deborah ; Walker, Patricia S.
Journal of the American Academy of Dermatology. 50 (2004) 3 - p. P17 , 2004

Link: https://doi.org/10.1016/..

11

A long-term, open-label study of the safety and efficacy of..:

Menter, Alan ; Lew-Kaya, Deborah ; Beddingfield, Frederick.
Journal of the American Academy of Dermatology. 50 (2004) 3 - p. P2 , 2004

Link: https://doi.org/10.1016/..

12

Tazarotene cream in the treatment of psoriasis: Two multice..:

Weinstein, Gerald D. ; Koo, John Y.M. ; Krueger, Gerald G....
Journal of the American Academy of Dermatology. 48 (2003) 5 - p. 760-767 , 2003

Link: https://doi.org/10.1067/..

13

Pharmacokinetics of Tazarotene Cream 0.1% After a Single Do..:

Yu, Zhiling ; Sefton, John ; Lew-Kaya, Deborah A...
Clinical Pharmacokinetics. 42 (2003) 10 - p. 921-929 , 2003

Link: https://doi.org/10.2165/..

14

Tazarotene 0.1% gel plus corticosteroid cream in the treatm..:

Lebwohl, Mark G. ; Breneman, Debra L. ; Goffe, Bernard S....
Journal of the American Academy of Dermatology. 39 (1998) 4 - p. 590-596 , 1998

Link: https://doi.org/10.1016/..

15

Tazarotene gel, a new retinoid, for topical therapy of psor..:

Weinstein, Gerald D. ; Krueger, Gerald G. ; Lowe, Nicholas J....
Journal of the American Academy of Dermatology. 37 (1997) 1 - p. 85-92 , 1997

Link: https://doi.org/10.1016/..